Article Text

Download PDFPDF

Treatment of hypercalcaemia in thyrotoxicosis with aminohydroxypropylidene diphosphonate.
  1. T. T. Tan,
  2. A. A. Alzaid,
  3. N. Sutcliffe,
  4. M. D. Gardner,
  5. J. A. Thomson,
  6. I. T. Boyle
  1. University Department of Medicine, Royal Infirmary, Glasgow, UK.


    Two patients had symptomatic hypercalcaemia accompanying thyrotoxicosis, despite initial treatment with volume repletion, beta blockade and antithyroid drugs. They were further managed with intravenous infusions of aminohydroxypropylidene diphosphonate resulting in rapid normalization of the serum calcium, with relief of symptoms. Aminohydroxypropylidene diphosphonate effectively suppressed the increased bone resorption of thyrotoxicosis without any undesirable adverse effects.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.